Neogenomics (NEO) Liabilities from Discontinued Operations (2025)
Neogenomics' (NEO) quarterly Liabilities from Discontinued Operations came in at 478000.0 in Q3 2025, up 4.82% on a QoQ basis from 456000.0 in Q2 2025.
Neogenomics (NEO) Liabilities from Discontinued Operations (2025) Analysis & Trends
Neogenomics (NEO) has 1 years of Liabilities from Discontinued Operations data on file, last reported at 478000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | Neogenomics | 2.04 Bn | 1.89 Bn | 91.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 478,000.00 |
| Sep 30, 2025 | 478,000.00 |
| Jun 30, 2025 | 456,000.00 |
| Jun 30, 2025 | 456,000.00 |